Carboplatin-etoposide chemotherapy (CB-ET) for patients diagnosed with advanced extra-pulmonary (EP) poorly differentiated (PD) neuroendocrine carcinoma (NEC): findings from a European Neuroendocrine Tumor Society Centre of Excellence.
Authors
Frizziero, MelissaLamarca, Angela
Kordatou, Zoe
Barriuso, Jorge
Nuttall, Christina
McNamara, Mairéad G
Hubner, Richard A
Mansoor, Was
Manoharan, Prakash
Valle, Juan W
Affiliation
The Christie NHS Foundation Trust, ManchesterIssue Date
2018